Cinclus Pharma Holding Ab
Clinical trials sponsored by Cinclus Pharma Holding Ab, explained in plain language.
-
New pill aims to outperform leading heartburn drug in Long-Term protection
Disease control Not yet recruitingThis study tests whether a new drug called linaprazan glurate works better than the approved drug lansoprazole at keeping the esophagus healed in people with chronic acid reflux disease (GERD). About 1,050 adults who have already healed their esophagus in a previous study will ta…
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
New pill aims to outperform standard heartburn drug in healing damaged esophagus
Disease control Not yet recruitingThis study is testing if a new drug called linaprazan glurate works better than the common medication lansoprazole at healing damage in the esophagus caused by severe acid reflux (GERD). About 500 adults with confirmed esophageal damage will be randomly assigned to take one of tw…
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC